Search
Patexia Research
Case number 1:19-cv-02100

Azurity Pharmaceuticals, Inc. v. Alkem Laboratories Ltd. > Documents

Date Field Doc. No.Description (Pages)
Aug 1, 2022 183 Main Document (22)
Docket Text: REDACTED VERSION of [182] Proposed Pretrial Order by Azurity Pharmaceuticals, Inc.. (Attachments: # (1) Exhibits 1-12)(Dellinger, Megan)
Aug 1, 2022 183 Exhibits 1-12 (579)
Jul 29, 2022 N/A Pretrial Conference (0)
Docket Text: Minute Entry for proceedings held before Judge Mitchell S. Goldberg - Telephonic Pretrial Conference held on 7/29/2022. (Court Reporter Carl Hauger.) (nmg)
Jul 22, 2022 181 Redacted Document (11)
Docket Text: REDACTED VERSION of [177] Letter by Azurity Pharmaceuticals, Inc.. (Dellinger, Megan)
Jul 13, 2022 180 Set Hearings (1)
Docket Text: ORDER, A Telephonic Pretrial Conference is set for 7/29/2022 at 01:00 PM before Judge Mitchell S. Goldberg. (See Order for dial-in information) Signed by Judge Mitchell S. Goldberg on 7/13/2022. (smg)
Jul 11, 2022 N/A Oral Order (0)
Docket Text: ORAL ORDER: The Court, having reviewed Plaintiff's discovery dispute motion ("Plaintiff's motion"), (D.I. 163), and the briefing related thereto, (D.I. 164; D.I. 165), and having heard argument on July 5, 2022, hereby ORDERS that Plaintiff's motion is DENIED for the reasons that follow: (1) Plaintiff's first argument -- and Plaintiff's primary reason for bringing its motion -- is that paragraphs 42-50 (the "paragraphs at issue") of the Rabinow Reply Report should be stricken because their content amounts to a shadow anticipation argument (that is, that Defendant means to use these paragraphs at issue to argue at trial that Allen 1998 and Vasotec anticipate certain of the asserted claims at issue). (D.I. 164 at 1) However, the Court has already ruled during the May 23, 2022 discovery dispute teleconference that Defendant's expert is not permitted to introduce such an argument. And Defendant has represented that they will not be relying on the paragraphs at issue to make a shadow anticipation argument. Rather, Defendant contends that the paragraphs at issue are relevant to objective indicia of nonobviousness. (D.I. 165 at 1, 3) Finally, to the extent that, despite all of this, Defendant does somehow attempt to make an anticipation argument at trial involving Allen 1998 and/or Vasotec, this is a bench trial, and the District Court will simply not permit it.; and (2) Second, Plaintiff argues that the paragraphs at issue are untimely in light of Plaintiff's Interrogatory No. 8 ("ROG No. 8"). (D.I. 164 at 2) The Court will assume arguendo that this is so, even though the history of the objective indicia issue in this case is a little tricky. (Although ROG No. 8 was served long ago, and although Defendant never offered a real substantive response to it, Plaintiff's position as to its own objective indicia case (which would have been helpful for Defendant to understand in responding to ROG No. 8) was not well fleshed out for most of this case.). Nevertheless, even if the paragraphs at issue are considered untimely, after further consideration, the Court concludes that the Pennypack factors weigh against striking them. After all, there are only 9 paragraphs at issue it is not a substantial amount of content. Plus, Plaintiff had the opportunity to question Dr. Rabinow regarding the paragraphs at issue. (See D.I. 164 at 3) And Plaintiff has served a responsive supplemental report (the "supplemental report") from Dr. Little that addresses the paragraphs at issue, (id.), which, as the Court will note below, it will permit Plaintiff to add to the record. Additionally, the Court has also reviewed Defendant's discovery dispute motion ("Defendant's motion"), (D.I. 168), and the briefing related thereto, (D.I. 172; D.I. 177). The Court hereby ORDERS that Defendant's motion also be DENIED. With the motion, Defendant seeks to strike the supplemental report. The Court considers Plaintiff to have previously made a request that the Court permit service of this report, (D.I. 177 at 2-3), which otherwise would be in violation of the operative Scheduling Order, (D.I. 172 at 1-2). The Court concludes that there is good cause to permit such service. Plaintiff was diligent in attempting to serve the supplemental report, having proffered it not long after it became aware of the paragraphs at issue in the Rabinow Reply Report -- and sufficiently in advance of Dr. Little's deposition so that Defendant could question Dr. Little about it. (D.I. 177 at 1-2 & ex. A) Permitting such service will not prejudice Defendant (Defendant makes no such argument that it will), and it will allow any possible prejudice to Plaintiff (regarding the Court's decision on Plaintiff's motion) to be mitigated. (D.I. 177 at 1, 3); see also British Telecommc'ns. PLC v. IAC/InterActive Corp, Civil Action No. 18-366-WCB, 2020 WL 3047989, at *2 (D. Del. June 8, 2020). In light of this decision, today's teleconference is CANCELLED. Ordered by Judge Christopher J. Burke on 7/11/2022. (mlc)
Jul 11, 2022 179 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Supplemental Report of Dr. Steven Little in Response to Dr. Rabinow's Opinions Regarding Allen 1998 filed by Azurity Pharmaceuticals, Inc..(Dellinger, Megan)
Jul 6, 2022 175 Main Document (4)
Docket Text: REDACTED VERSION of [172] Letter, to The Honorable Christopher J. Burke from R Touhey Myer regarding Discovery Dispute by Alkem Laboratories Ltd.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Text of Proposed Order, # (4) Certificate of Service)(Myer, R.)
Jul 6, 2022 175 Exhibit A (18)
Jul 6, 2022 175 Exhibit B (3)
Jul 6, 2022 175 Text of Proposed Order (1)
Jul 6, 2022 175 Certificate of Service (2)
Jul 6, 2022 176 Redacted Document (2)
Docket Text: REDACTED VERSION of [173] Declaration of George J. Barry III in Support of Defendant's Letter to the Honorable Christopher J. Burke Regarding Discovery Dispute by Alkem Laboratories Ltd.. (Myer, R.)
Jul 5, 2022 N/A Discovery Conference (0)
Docket Text: Minute Entry for proceedings held before Judge Christopher J. Burke - Discovery dispute teleconference held on 7/5/2022. The Court heard argument from the parties regarding Plaintiff's discovery dispute motion, (D.I. [163]). The Court will issue an order resolving the motion. (Court Reporter Ellie Corbett. Clerk: M. Crawford) Appearances: M. Dellinger, W. Devine for Plaintiff; T. Myer, G. Barry, M. Hogan for Defendant. (mlc)
Jun 30, 2022 174 Main Document (5)
Docket Text: REDACTED VERSION of [164] Letter by Azurity Pharmaceuticals, Inc.. (Attachments: # (1) Exhibits A-L, # (2) Text of Proposed Order)(Dellinger, Megan)
Jun 30, 2022 174 Exhibits A-L (136)
Jun 30, 2022 174 Text of Proposed Order (1)
Jun 28, 2022 170 Main Document (5)
Docket Text: REDACTED VERSION of [165] Letter, to The Honorable Christopher J. Burke from R Touhey Myer regarding Defendant's Response in Opposition to Plaintiff's Letter Regarding Discovery Dispute by Alkem Laboratories Ltd.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Text of Proposed Order, # (9) Certificate of Service)(Myer, R.)
Jun 28, 2022 170 Exhibit 1 (28)
Jun 28, 2022 170 Exhibit 2 (29)
Jun 28, 2022 170 Exhibit 3 (20)
Jun 28, 2022 170 Exhibit 4 (3)
Jun 28, 2022 170 Exhibit 5 (21)
Jun 28, 2022 170 Exhibit 6 (4)
Jun 28, 2022 170 Exhibit 7 (17)
Jun 28, 2022 170 Text of Proposed Order (1)
Jun 28, 2022 170 Certificate of Service (2)
Jun 28, 2022 171 Redacted Document (3)
Docket Text: REDACTED VERSION of [166] Declaration, of George J. Barry III in Support of Defendant's Response in Opposition to Plaintiff's Letter to the Honorable Christopher J. Burke Regarding Discovery Dispute by Alkem Laboratories Ltd.. (Myer, R.)
Jun 23, 2022 N/A Order Setting Teleconference (0)
Docket Text: ORAL ORDER Setting Teleconference: The Court has reviewed the parties' June 21, 2022 letter requesting a discovery dispute teleconference regarding one discovery dispute. (D.I. 167) It hereby ORDERS that the procedures for resolving a discovery dispute set out in the Scheduling Order will be modified as follows with regard to this dispute: (1) A discovery dispute teleconference is set for July 11, 2022 at 11:00 AM before Judge Christopher J. Burke.; (2) By June 29, 2022, any party seeking relief shall file with the Court a letter, not to exceed three (3) single-spaced pages, in no less than 12-point font, outlining the issues in dispute and its position on those issues. By July 6, 2022, any party opposing the application for relief may file a letter, not to exceed three (3) single-spaced pages, in no less than 12-point font, outlining that party's reasons for its opposition.; (3) The parties should also consult and follow Judge Burke's "Guidelines for Discovery Disputes," which is found in the "Guidelines" tab on Judge Burke's portion of the District Court's website.; (4) By no later than June 30, 2022, the parties shall jointly provide the Court's Courtroom Deputy, Ms. Benyo, with a dial-in number via e-mail to use for the call.; and (5) The Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the teleconference (however, if any party advises the Court in advance that a newer attorney will argue the dispute, see Standing Order Regarding Courtroom Opportunities for Newer Attorneys, https://www.ded.uscourts.gov/sites/ded/files/StandingOrder2017.pdf, then the Court will go forward with the conference). Ordered by Judge Christopher J. Burke on 6/23/2022. (dlb)
Jun 21, 2022 167 Letter (2)
Docket Text: Letter to The Honorable Christopher J. Burke from R Touhey Myer regarding Joint Letter re Motion for Teleconference to Resolve Discovery Dispute. (Myer, R.)
Jun 21, 2022 168 Motion for Miscellaneous Relief (2)
Docket Text: MOTION for Teleconference to Resolve Discovery Dispute re [167] Letter - filed by Alkem Laboratories Ltd.. (Myer, R.)
Jun 14, 2022 163 Motion for Miscellaneous Relief (1)
Docket Text: Joint MOTION for Teleconference to Resolve Discovery Dispute - filed by Azurity Pharmaceuticals, Inc.. (Dellinger, Megan)
Jun 10, 2022 162 Main Document (2)
Docket Text: REDACTED VERSION of [157] Letter to The Honorable Christopher J. Burke from R Touhey Myer regarding Rabinow Reply Report by Alkem Laboratories Ltd.. (Attachments: # (1) Exhibit A)(Myer, R.)
Jun 10, 2022 162 Exhibit A (70)
Jun 9, 2022 159 Notice to Take Deposition (2)
Docket Text: NOTICE to Take Deposition of John D. Mahan, Jr., M.D. on June 10, 2022 filed by Alkem Laboratories Ltd..(Myer, R.)
Jun 9, 2022 160 Notice to Take Deposition (2)
Docket Text: NOTICE to Take Deposition of Dr. Steven Little on June 14, 2022 filed by Alkem Laboratories Ltd..(Myer, R.)
Jun 9, 2022 161 Main Document (2)
Docket Text: REDACTED VERSION of [156] Letter by Azurity Pharmaceuticals, Inc.. (Attachments: # (1) Exhibits A-D)(Dellinger, Megan)
Jun 9, 2022 161 Exhibits A-D (9)
Jun 7, 2022 N/A Order Setting Teleconference (0)
Docket Text: ORAL ORDER: The Court, having reviewed the parties' letters regarding Dr. Rabinow's reply report (the "Rabinow reply report"), (D.I. 156; D.I. 157), hereby ORDERS as follows: (1) Because Plaintiff is requesting that the Court strike material in the Rabinow reply report (whereas the Court's prior order pertained to Dr. Rabinow's responsive report), Plaintiff should have followed the Court's regular discovery dispute procedures to raise this issue.; (2) The Court offers the following guidance as to how it would probably look at the issue based on the limited information it currently has before it: Just because the Court struck certain content with respect to the prior dispute, (D.I. 147), that does not mean that there is no chance that Defendant could utilize the material no matter what. Rather, the relevant questions would be: (a) whether this content truly is responsive to a secondary considerations argument put forward by Plaintiff's expert; and (b) whether this content should have been earlier disclosed in the case by Defendant (such as if, for example, Plaintiff earlier propounded an interrogatory request regarding Defendant's response to Plaintiff's already-disclosed secondary considerations arguments). If the answer to (a) is yes and the answer to (b) is no, then presumably it would be okay for this content to appear in Dr. Rabinow's reply report. But if the answer to (a) is yes and the answer to (b) is yes, then presumably this material would be untimely disclosed, and application of the Pennypack factors would not likely save this material, with trial coming up in August.; (3) The parties should further meet and confer in light of the Court's guidance by close of business on June 8, 2022.; (4) To the extent the parties' dispute is not resolved during the meet and confer process, the parties shall file a joint "Motion for Teleconference to Resolve Discovery Dispute," the text of which can be found in the "Forms" tab of Judge Burke's page on the District Court's website. (If the parties' dispute is resolved during that process, the parties should file a joint letter advising the Court as such.).; (5) Assuming it is needed, a discovery dispute teleconference is set for July 5, 2022 at 1:00 PM before Judge Christopher J. Burke.; (6) By June 14, 2022, Plaintiff shall file with the Court a letter, not to exceed three (3) single-spaced pages, in no less than 12-point font, outlining the issues in dispute and its position on those issues. By June 21, 2022, Defendant may file a letter, not to exceed three (3) single-spaced pages, in no less than 12-point font, outlining its reasons for its opposition.; (7) The parties should also consult and follow Judge Burke's "Guidelines for Discovery Disputes," which is found in the "Guidelines" tab on Judge Burke's portion of the District Court's website.; (8) By no later than June 29, 2022, the parties shall jointly provide the Court's Courtroom Deputy, Deborah Benyo, with a dial-in number via e-mail to use for the call.; (9) The Court may choose to resolve the Motion prior to the telephone conference and will, in that event, cancel the conference (however, if any party advises the Court in advance that a newer attorney will argue the Motion, see Standing Order Regarding Courtroom Opportunities for Newer Attorneys, https://www.ded.uscourts.gov/sites/ded/files/StandingOrder2017.pdf, then the Court will go forward with the conference).; and (10) To the extent that Dr. Rabinow's deposition must occur in the meantime, (D.I. 156 at 2), Plaintiff shall assume that the material at issue is in the case for now and proceed accordingly at the deposition. Ordered by Judge Christopher J. Burke on 6/7/2022. (dlb)
Jun 2, 2022 155 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Reply Report of Dr. Steven Little Regarding Infringement of U.S. Patent Nos. 10,786,482 and 10,918,621 filed by Azurity Pharmaceuticals, Inc..(Dellinger, Megan)
Jun 1, 2022 153 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Defendant's Reply Expert Report of Barrett E. Rabinow, Ph.D. in Support of Patent Invalidity filed by Alkem Laboratories Ltd..(Myer, R.)
Jun 1, 2022 154 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Defendant's Reply Expert Report of Panayiotis P. Constantinides, Ph.D. in Support of Invalidity filed by Alkem Laboratories Ltd..(Myer, R.)
May 31, 2022 151 Order on Motion to Appear Pro Hac Vice (2)
Docket Text: ORDER granting [148] Motion to Appear Pro Hac Vice for Evan T. Sumner. Signed by Judge Mitchell S. Goldberg on 5/31/2022. (twk)
May 31, 2022 152 Order (1)
Docket Text: ORDER, the 5-day Bench Trial scheduled for August 8, 2022 is RESCHEDULED to be held on Tuesday, August 16, 2022 in a Courtroom to be determined in Wilmington, Delaware. Signed by Judge Mitchell S. Goldberg on 5/31/2022. (twk)
May 26, 2022 148 Motion for Leave to Appear Pro Hac Vice (4)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Evan T. Sumner - filed by Azurity Pharmaceuticals, Inc.. (Dellinger, Megan)
May 26, 2022 149 Main Document (5)
Docket Text: REDACTED VERSION of [144] Letter, to The Honorable Christopher J. Burke from R Touhey Myer regarding Defendant's Response in Opposition to Plaintiff's Letter Regarding Discovery Dispute by Alkem Laboratories Ltd.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Text of Proposed Order, # (4) Certificate of Service)(Myer, R.)
May 26, 2022 149 Exhibit A (10)
May 26, 2022 149 Exhibit B (20)
May 26, 2022 149 Text of Proposed Order (2)
May 26, 2022 149 Certificate of Service (2)
May 26, 2022 150 Redacted Document (2)
Docket Text: REDACTED VERSION of [145] Declaration of George J. Barry III in Support of Opposition to Plaintiff's Letter to the Honorable Christopher J. Burke Regarding Discovery Dispute by Alkem Laboratories Ltd.. (Myer, R.)
May 24, 2022 N/A Oral Order (0)
Docket Text: ORAL ORDER: With regard to the remaining portion of Plaintiff's discovery dispute motion, (the "Motion"), (D.I. 142), that the Court did not resolve during the May 23, 2022 teleconference with the parties, the Court hereby ORDERS that Plaintiff's request is DENIED. Here, Plaintiff argues that portions of paragraph 6 as well as paragraphs 81-105 and 137-42 (the "paragraphs at issue") of the Rabinow Report should be stricken because they contain previously undisclosed invalidity opinions relating to patent utility and enablement. (D.I. 143 at 2) However, Defendant's responsive letter attached certain of its prior non-infringement contentions, in which it made clear that Defendant intended to make a non-infringement argument that the scope of certain asserted claims excludes formulations containing both parabens and sugars or sugar alcohols (and that the specification of certain patents warns against the use of paraben preservatives in conjunction with specific sugars and sugar alcohols)and that Defendant is in fact making that same non-infringement argument in the paragraphs at issue. (D.I. 144, ex. A at 3, 5; see also, e.g., D.I. 39, ex. F at 13:9-15) To the extent that Plaintiff responded by asserting that the content of the paragraphs at issue was not sufficiently disclosed in Defendants prior non-infringement contentions because the paragraphs at issue discuss toxicity associated with combining parabens and sugar/sugar alcohols, the Court does not agree. The paragraphs at issue expand upon Defendant's previously-disclosed non-infringement position, and an expert is permitted to expand upon previously-disclosed theories. See, e.g., TQ Delta, LLC v. ADTRAN, Inc., Civil Action No. 14-954-RGA, 2021 WL 3728919, at *4 (D. Del. Aug. 23, 2021). Ordered by Judge Christopher J. Burke on 5/24/2022. (dlb)
May 23, 2022 N/A Discovery Conference (0)
Docket Text: Minute Entry for proceedings held before Judge Christopher J. Burke - Discovery dispute teleconference held on 5/23/2022. The Court heard argument from the parties' regarding Plaintiff's motion, (D.I. 142). The Court resolved some of the motion during the teleconference. The transcript shall serve as the substance of the Court's order. The Court will issue an order resolving the remaining portion of the motion shortly. (Court Reporter Michele Rolfe. Clerk: M. Crawford) Appearances: M. Dellinger, K. Hanson for Plaintiff; T. Myer, G. Barry for Defendant. (mlc)
May 23, 2022 146 Redacted Document (15)
Docket Text: REDACTED VERSION of [143] Letter by Azurity Pharmaceuticals, Inc.. (Dellinger, Megan)
May 16, 2022 142 Motion for Miscellaneous Relief (1)
Docket Text: Joint MOTION for Teleconference to Resolve Discovery Disputes - filed by Azurity Pharmaceuticals, Inc.. (Dellinger, Megan)
May 13, 2022 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Michael P. Hogan for Alkem Laboratories Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk)
May 12, 2022 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney T.O. Kong for Azurity Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb)
May 12, 2022 140 Letter (2)
Docket Text: Letter to The Honorable Christopher J. Burke from Megan E. Dellinger regarding discovery dispute and request to expedite. (Dellinger, Megan)
May 12, 2022 N/A Order Setting Teleconference (0)
Docket Text: ORAL ORDER Setting Teleconference: The Court has reviewed Plaintiff's May 12, 2022 letter requesting an expedited discovery dispute teleconference regarding one discovery dispute. (D.I. 140) It hereby ORDERS that the procedures for resolving a discovery dispute set out in the Court's October 12, 2021 Oral Order, (D.I. 87), will be modified as follows with regard to this dispute: (1) The parties shall meet and confer regarding the dispute by close of business on May 13, 2022.; (2) To the extent the parties' dispute is not resolved during the meet and confer process, the parties shall file a joint "Motion for Teleconference to Resolve Discovery Dispute," the text of which can be found in the "Forms" tab of Judge Burke's page on the District Court's website. (If the parties dispute is resolved during that process, the parties should file a joint letter advising the Court as such.).; (3) Assuming it is needed, a discovery dispute teleconference is set for May 23, 2022 at 2:30 PM before Judge Christopher J. Burke.; (4) By May 16, 2022, Plaintiff shall file with the Court a letter, not to exceed three (3) single-spaced pages, in no less than 12-point font, outlining the issues in dispute and its position on those issues. By May 19, 2022, Defendant may file a letter, not to exceed three (3) single-spaced pages, in no less than 12-point font, outlining its reasons for its opposition.; (5) The parties should also consult and follow Judge Burke's "Guidelines for Discovery Disputes," which is found in the "Guidelines" tab on Judge Burke's portion of the District Court's website.; (6) By no later than May 19, 2022, the parties shall jointly provide the Court's Courtroom Deputy, Deborah Benyo, with a dial-in number via e-mail to use for the call.; and (7) The Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference. Ordered by Judge Christopher J. Burke on 5/12/2022. (dlb)
May 9, 2022 138 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of (1) Responsive Expert Report of Dr. Steven Little on the Validity of U.S. Patent Nos. 10,786,482 and 10,918,621 and (2) Expert Report of John D. Mahan, J.R., M.D. on Objective Indicia of Non-Obviousness for U.S. Patents 10,786,482 and 10,918,621 filed by Azurity Pharmaceuticals, Inc..(Dellinger, Megan)
May 9, 2022 139 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Noninfringement Rebuttal Expert Report of Barrett E. Rabinow, Ph.D. filed by Alkem Laboratories Ltd..(Myer, R.)
May 2, 2022 137 Transcript (57)
Docket Text: Official Transcript of Status Hearing held on 4/25/2022 before Judge Mitchell S. Goldberg. Court Reporter/Transcriber Michael T. Keating, Phone: (609) 440-2177. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER Redaction Request due 5/23/2022. Redacted Transcript Deadline set for 6/2/2022. Release of Transcript Restriction set for 8/1/2022. Associated Cases: 1:18-cv-01962-MSG et al.(nmg)
Apr 25, 2022 N/A Status Conference (0)
Docket Text: Minute Entry for proceedings held before Judge Mitchell S. Goldberg - Zoom Status Conference held on 4/25/2022. (Court Reporter Jimmy Cruz.) Associated Cases: 1:18-cv-01962-MSG et al. (nmg)
Apr 14, 2022 136 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Opening Expert Report of Dr. Steven Little filed by Azurity Pharmaceuticals, Inc..(Dellinger, Megan)
Apr 13, 2022 134 Status Report (9)
Docket Text: Joint STATUS REPORT by Azurity Pharmaceuticals, Inc.. (Dellinger, Megan)
Apr 13, 2022 135 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Opening Expert Report of Panayiotis P. Constantinides, Ph.D. filed by Alkem Laboratories Ltd..(Myer, R.)
Apr 12, 2022 133 Redacted Document (3)
Docket Text: REDACTED VERSION of [131] Letter by Azurity Pharmaceuticals, Inc.. (Dellinger, Megan)
Apr 11, 2022 N/A Case No Longer Referred to Mediation (0)
Docket Text: CASE NO LONGER REFERRED to Magistrate Judge Burke for the purpose of exploring ADR. Please see the Court's Standing Order No. 2022-2 dated March 14, 2022. (dlb)
Apr 4, 2022 132 Notice (Other) (1)
Docket Text: NOTICE of Withdrawal of Kenneth L. Dorsney, Cortlan S. Hitch and Morris James LLP for Alkem Laboratories Ltd. by Alkem Laboratories Ltd. (Myer, R.)
Mar 30, 2022 130 Order (2)
Docket Text: ORDER, A status conference will be held on the record, by video conference, on Monday, April 25, 2022, at 3:00 p.m. Chambers will contact the parties with details for joining the video conference. Counsel for all parties shall meet and confer and, within fourteen (14) days of the date of this Order, file a joint letter summarizing the status of each of the above cases. Signed by Judge Mitchell S. Goldberg on 3/30/2022. Associated Cases: 1:18-cv-01962-MSG et al. (nmg)
Mar 22, 2022 129 Scheduling Order (2)
Docket Text: STIPULATION and ORDER AMENDING CASE SCHEDULE: Opening Expert Reports due by 4/13/2022. Rebuttal Expert Reports due by 5/6/2022. Reply Expert Reports due by 6/1/2022. Expert Discovery due by 6/14/2022. Signed by Judge Mitchell S. Goldberg on 3/21/2022. (nmg)
Mar 21, 2022 128 Stipulation (2)
Docket Text: STIPULATION and [Proposed] Order Amending Case Schedule by Azurity Pharmaceuticals, Inc.. (Dellinger, Megan)
Mar 18, 2022 127 Scheduling Order (2)
Docket Text: STIPULATION and ORDER Amending Case Schedule. Signed by Judge Mitchell S. Goldberg on 3/18/2022. (nmg)
Mar 9, 2022 126 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Second Amended Infringement Claim Charts filed by Azurity Pharmaceuticals, Inc..(Dellinger, Megan)
Mar 7, 2022 124 Order on Motion to Appear Pro Hac Vice (1)
Docket Text: ORDER granting [123] Motion to Appear Pro Hac Vice for Michael P. Hogan. Signed by Judge Mitchell S. Goldberg on 03/07/2022. (smg)
Mar 7, 2022 125 Stipulation (2)
Docket Text: STIPULATION and [Proposed] Order Amending Case Schedule re [83] SO ORDERED,, Set Deadlines/Hearings, by Azurity Pharmaceuticals, Inc.. (Dellinger, Megan)
Mar 3, 2022 123 Motion for Leave to Appear Pro Hac Vice (2)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Michael P. Hogan - filed by Alkem Laboratories Ltd.. (Dorsney, Kenneth)
Mar 2, 2022 N/A Case Assigned/Reassigned (0)
Docket Text: Case Reassigned to Judge Mitchell S. Goldberg of the United States District Court for the Eastern District of Pennsylvania. Please include the initials of the Judge (MSG) after the case number on all documents filed. Associated Cases: 1:18-cv-01962-MSG, 1:19-cv-01067-MSG, 1:19-cv-02100-MSG, 1:20-cv-01256-MSG, 1:21-cv-00196-MSG, 1:21-cv-01286-MSG, 1:21-cv-01455-MSG, and 1:21-cv-01707-MSG. (rjb)
Feb 25, 2022 122 Status Report (8)
Docket Text: Joint STATUS REPORT by Azurity Pharmaceuticals, Inc., Silvergate Pharmaceuticals, Inc.. (Dellinger, Megan)
Feb 23, 2022 N/A Order (0)
Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that in anticipation of reassignment of these cases (C.A. Nos. 18-1962, 19-1067, 19-2100, 21-196, 21-1286, 21-1455, 21-1707) to another judge, the parties shall meet and confer and, no later than February 25, submit a joint status report (one that collectively addresses all of these related cases), advising the Court of the following (in addition to anything else the parties wish to report): (i) whether trial has occurred and/or is scheduled to occur and if so, when; (ii) whether a preliminary injunction motion has been litigated and whether any preliminary injunction motion is anticipated; (iii) the date of expiration of any regulatory stay, if applicable; and (iv) the status of any pending motions, or any motions the parties anticipate filing, and the urgency (if any) of such motions. ORDERED by Judge Leonard P. Stark on 2/23/22. Associated Cases: 1:18-cv-01962-LPS et al. (ntl)
Feb 22, 2022 120 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Defendant Alkem Laboratories Ltd.'s Amended First Supplemental Invalidity Contentions regarding U.S. Patent Nos. 10,786,482 B2 and 10,918,621 B2 filed by Alkem Laboratories Ltd..(Dorsney, Kenneth)
Feb 10, 2022 118 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Amended Infringement Claim Charts filed by Azurity Pharmaceuticals, Inc..(Dellinger, Megan)
Feb 10, 2022 119 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Defendant Alkem Laboratories Ltd.'s First Supplemental Invalidity Contentions regarding U.S. Patent Nos. 10,786,482 B2 and 10,918,621 B2 filed by Alkem Laboratories Ltd..(Dorsney, Kenneth)
Feb 3, 2022 117 Notice to Take Deposition (3)
Docket Text: NOTICE to Take Deposition of Manas Pradhan on February 3, 2022 filed by Azurity Pharmaceuticals, Inc..(Dellinger, Megan)
Feb 2, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [116] MOTION for Pro Hac Vice Appearance of Attorney Ty W. Callahan filed by Azurity Pharmaceuticals, Inc. Signed by Judge Leonard P. Stark on 2/2/22. (ntl)
Feb 2, 2022 116 Motion for Leave to Appear Pro Hac Vice (4)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Ty W. Callahan - filed by Azurity Pharmaceuticals, Inc.. (Dellinger, Megan)
Jan 31, 2022 113 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Responses to notice of 30(b)(6) deposition to Alkem filed by Alkem Laboratories Ltd..(Dorsney, Kenneth)
Jan 31, 2022 114 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Objections and Responses to Defendant's Notice of Rule 30(b)(6) Deposition filed by Azurity Pharmaceuticals, Inc..(Dellinger, Megan)
Jan 31, 2022 115 Status Report (2)
Docket Text: Supplemental STATUS REPORT by Azurity Pharmaceuticals, Inc.. (Dellinger, Megan)
Jan 28, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (112 in 1:19-cv-02100-LPS, 102 in 1:21-cv-00196-LPS) MOTION for Pro Hac Vice Appearance of Attorney Jody Karol filed by Azurity Pharmaceuticals, Inc. Signed by Judge Leonard P. Stark on 1/28/22. Associated Cases: 1:19-cv-02100-LPS, 1:21-cv-00196-LPS (ntl)
Jan 28, 2022 112 Motion for Leave to Appear Pro Hac Vice (4)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jody Karol - filed by Azurity Pharmaceuticals, Inc.. (Dellinger, Megan)
Jan 25, 2022 111 Redacted Document (3)
Docket Text: REDACTED VERSION of [106] Notice to Take Deposition by Azurity Pharmaceuticals, Inc.. (Dellinger, Megan)
Jan 21, 2022 107 Notice to Take Deposition (12)
Docket Text: NOTICE to Take Deposition of Azurity Pharmaceuticals Inc. filed by Alkem Laboratories Ltd..(Dorsney, Kenneth)
Jan 21, 2022 108 Notice to Take Deposition (2)
Docket Text: NOTICE to Take Deposition of Michael Beckloff on February 4, 2022 filed by Alkem Laboratories Ltd..(Dorsney, Kenneth)
Jan 21, 2022 109 Notice to Take Deposition (2)
Docket Text: NOTICE to Take Deposition of Gerold Mosher on February 8, 2022 filed by Alkem Laboratories Ltd..(Dorsney, Kenneth)
Jan 21, 2022 110 Notice to Take Deposition (2)
Docket Text: NOTICE to Take Deposition of David Miles on February 9, 2022 filed by Alkem Laboratories Ltd..(Dorsney, Kenneth)
Jan 18, 2022 103 Notice to Take Deposition (3)
Docket Text: NOTICE to Take Deposition of Prashant Mandaogade filed by Azurity Pharmaceuticals, Inc..(Dellinger, Megan)
Jan 18, 2022 104 Notice to Take Deposition (3)
Docket Text: NOTICE to Take Deposition of Somnath Gadhave filed by Azurity Pharmaceuticals, Inc..(Dellinger, Megan)
Jan 18, 2022 105 Notice to Take Deposition (3)
Docket Text: NOTICE to Take Deposition of Ujwal Chhabra filed by Azurity Pharmaceuticals, Inc..(Dellinger, Megan)
Jan 12, 2022 102 Status Report (4)
Docket Text: Interim STATUS REPORT by Azurity Pharmaceuticals, Inc.. (Dellinger, Megan)
Jan 6, 2022 N/A CORRECTING ENTRY: (0)
Docket Text: CORRECTING ENTRY: Notice of Service filed at D.I. 102 has been removed from the docket per request of counsel. (ntl)
Dec 9, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [101] STIPULATION and [Proposed] Order to Stay Pending Appeal (as to certain patents) filed by Azurity Pharmaceuticals, Inc. Signed by Judge Leonard P. Stark on 12/9/21. (ntl)
Dec 8, 2021 101 Stipulation (2)
Docket Text: STIPULATION and [Proposed] Order to Stay Pending Appeal by Azurity Pharmaceuticals, Inc.. (Dellinger, Megan)
Nov 22, 2021 100 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Alkem Laboratories Ltd.'s Second Supplemental Responses and Objections to Plaintiffs' Common Interrogatory No. 5 filed by Alkem Laboratories Ltd..(Dorsney, Kenneth)
Nov 18, 2021 99 Notice of Appearance (1)
Docket Text: NOTICE of Appearance by R. Touhey Myer on behalf of Alkem Laboratories Ltd. (Myer, R.)
Nov 16, 2021 97 Memorandum Opinion (15)
Docket Text: MEMORANDUM OPINION re claim construction. Signed by Judge Leonard P. Stark on 11/16/21. (ntl)
Nov 16, 2021 98 Order (1)
Docket Text: ORDER re [97] Memorandum Opinion regarding claim construction. Signed by Judge Leonard P. Stark on 11/16/21. (ntl) (ntl).
Nov 8, 2021 N/A Discovery Conference (0)
Docket Text: Minute Entry for proceedings held before Judge Christopher J. Burke - Discovery Conference held on 11/8/2021. The Court heard argument from the parties regarding the discovery dispute motion. (D.I. 89) The Court resolved the parties' disputes. The transcript shall serve as the substance of the Court's order. (Court Reporter Stacy Vickers (Hawkins). Clerk: M. Crawford) Appearances: M. Dellinger, T. Kong and N. Halkowski for Plaintiff; C. Hitch and T. Kratzfor Defendant. (mlc)
Nov 5, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [96] MOTION for Pro Hac Vice Appearance of Attorney Nicholas Halkowski filed by Azurity Pharmaceuticals, Inc. Signed by Judge Leonard P. Stark on 11/5/21. (ntl)
Nov 4, 2021 96 Motion for Leave to Appear Pro Hac Vice (4)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Nicholas Halkowski - filed by Azurity Pharmaceuticals, Inc.. (Dellinger, Megan)
Nov 2, 2021 95 Main Document (1)
Docket Text: PROPOSED ORDER re [90] Letter by Azurity Pharmaceuticals, Inc.. (Attachments: # (1) Letter to The Honorable Christopher J. Burke)(Dellinger, Megan)
Nov 2, 2021 95 Letter to The Honorable Christopher J. Burke (1)
Nov 1, 2021 94 Redacted Document (30)
Docket Text: REDACTED VERSION of [90] Letter by Azurity Pharmaceuticals, Inc.. (Dellinger, Megan)
Oct 27, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED D.I. [93] STIPULATION TO EXTEND TIME for plaintiff to file a redacted version of its letter regarding a discovery dispute to November 2, 2021 filed by Azurity Pharmaceuticals, Inc. Ordered by Judge Christopher J. Burke on 10/27/2021. (dlb)
Oct 26, 2021 92 Letter (3)
Docket Text: Letter to The Honorable Christopher J. Burke from Kenneth L. Dorsney regarding Response to Discovery Dispute Letter - re [90] Letter. (Dorsney, Kenneth)
Oct 26, 2021 93 Stipulation to EXTEND Time (1)
Docket Text: STIPULATION TO EXTEND TIME for plaintiff to file a redacted version of its letter regarding a discovery dispute to November 2, 2021 - filed by Azurity Pharmaceuticals, Inc.. (Dellinger, Megan)
Oct 25, 2021 N/A Remark (0)
Docket Text: Remark: The Court recognizes that it is now more than 60 days since the claim construction hearing. The Court currently anticipates issuing its order regarding claim construction by on or around November 22. (ntl)
Oct 19, 2021 89 Motion for Miscellaneous Relief (2)
Docket Text: MOTION for Teleconference to Resolve Discovery Dispute - filed by Azurity Pharmaceuticals, Inc.. (Dellinger, Megan)
Oct 13, 2021 N/A Order (0)
Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that the Referral Order at D.I. 85 is WITHDRAWN. IT IS FURTHER ORDERED that this case is referred to Magistrate Judge Christopher J. Burke, pursuant to 28 U.S.C. § 636(b), to hear and resolve all discovery disputes (including D.I. 84). ORDERED by Judge Leonard P. Stark on 10/13/21. (ntl)
Oct 12, 2021 N/A Remark (0)
Docket Text: Remark: The parties should be aware that the Court encourages the participation of newer attorneys in courtroom proceedings and at oral argument. Please see the Court's Standing Order Regarding Courtroom Opportunities for Newer Attorneys, a link to which is provided here for the parties' convenience:http://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrder2017.pdf (mlc)
Oct 12, 2021 N/A Remark (0)
Docket Text: Remark: The parties should follow the Court's Standing Order Regarding Courtesy Copies, a copy of which is found on Judge Burke's portion of the District Court's webpage: https://www.ded.uscourts.gov/judge/magistrate-judge-christopher-j-burke (mlc)
Oct 12, 2021 N/A Order Setting Teleconference (0)
Docket Text: ORAL ORDER Setting Teleconference: The Court has reviewed the parties' September 20, 2021 letter requesting a discovery dispute teleconference regarding one discovery dispute. (D.I. 84) It hereby ORDERS that the procedures for resolving a discovery dispute set out in the Scheduling Order will be modified as follows with regard to this dispute: (1) The parties shall file a joint "Motion for Teleconference to Resolve Discovery Dispute," the text of which can be found in the "Forms" tab of Judge Burke's page on the District Court's website.; (2) A discovery dispute teleconference is set for 11/8/2021 at 01:00 PM before Judge Christopher J. Burke.; (3) On October 19, 2021, any party seeking relief shall file with the Court a letter, not to exceed two (2) single-spaced pages, in no less than 12-point font, outlining the issues in dispute and its position on those issues. On October 26, 2021, any party opposing the application for relief may file a letter, not to exceed two (2) single-spaced pages, in no less than 12-point font, outlining that party's reasons for its opposition.; (4) The parties should also consult Judge Burke's "Guidelines for Discovery Disputes," which is found in the "Guidelines" tab on Judge Burke's portion of the District Court's website.; (5) By no later than November 3, 2021, the parties shall jointly provide the Court's Courtroom Deputy, Ms. Benyo, with a dial-in number via e-mail to use for the call.; and (6) The Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference.Ordered by Judge Christopher J. Burke on 10/12/2021. (mlc)
Oct 12, 2021 N/A Oral Order (0)
Docket Text: ORAL ORDER: The Court, having reviewed the case history in light of the October 8, 2021 referral, hereby ORDERS that the procedures for resolving a dispute relating to discovery or the protective order set out in the Scheduling Order, (D.I. 15 at 7-8), will be modified as follows: Should counsel find, after good faith efforts including verbal communication among Delaware and Lead Counsel for all parties to the dispute, that they are unable to resolve a discovery or protective order matter, the parties involved in the dispute shall submit a joint letter with the text set out in the Court's standard Rule 16 Scheduling Order for Patent cases, which can be found in the "Forms" tab of Magistrate Judge Burke's page on the District Court's website. For disputes relating to discovery, the moving party (i.e., the party seeking relief from the Court) should also file a Motion For Teleconference To Resolve Discovery Dispute, and for disputes relating to protective orders, the parties shall file a Joint Motion for Teleconference to Resolve Protective Order Dispute. The suggested text for these motions can be found in the same Forms tab. The Court will thereafter set a discovery or protective order dispute telephone conference and letter briefing schedule. Ordered by Judge Christopher J. Burke on 10/12/2021. (mlc)
Oct 8, 2021 N/A Order Referring Case to Magistrate Judge (0)
Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that this case is referred to Magistrate Judge Christopher J. Burke to hear and resolve all pre-trial matters up to and including expert discovery matters (but not including summary judgment motions, Daubert motions, pre-trial motions in limine or the pre-trial conference), subject to 28 U.S.C. § 636(b) and any further Order of the Court. ORDERED by Judge Leonard P. Stark on 10/8/21. (ntl)
Sep 20, 2021 84 Letter (2)
Docket Text: Letter to The Honorable Leonard P. Stark from Megan E. Dellinger regarding request for discovery teleconference. (Dellinger, Megan)
Sep 14, 2021 83 SO ORDERED (3)
Docket Text: SO ORDERED, re [81] Joint MOTION to Amend the Case Schedule and Set a New Trial Date -- Fact Discovery completed by 2/10/2022. Proposed Pretrial Order due by 7/22/2022. Status Report due by 1/12/2022. A 5-day Bench Trial is set for 8/8/2022 at 08:30 AM in Courtroom 6B before Judge Leonard P. Stark. A Final Pretrial Conference is set for 7/29/2022 at 04:00 PM in Courtroom 6B before Judge Leonard P. Stark. Signed by Judge Leonard P. Stark on 9/14/21. (ntl)
Sep 10, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [82] STIPULATION TO EXTEND TIME for the parties to submit a joint status report to September 16, 2021 filed by Azurity Pharmaceuticals, Inc. Signed by Judge Leonard P. Stark on 9/10/21. (ntl)
Sep 9, 2021 82 Stipulation to EXTEND Time (1)
Docket Text: STIPULATION TO EXTEND TIME for the parties to submit a joint status report to September 16, 2021 - filed by Azurity Pharmaceuticals, Inc.. (Dellinger, Megan)
Sep 2, 2021 81 Motion for Extension of Time (3)
Docket Text: Joint MOTION for Extension of Time to Set New Trial Date and Amend Case Schedule - filed by Alkem Laboratories Ltd.. (Hitch, Cortlan)
Aug 31, 2021 80 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Alkem's First Supplemental Responses to Azurity's First Set of Common Interrogatories (Nos. 2-5, 7 and 9) filed by Alkem Laboratories Ltd..(Dorsney, Kenneth)
Aug 30, 2021 79 Transcript (53)
Docket Text: Official Transcript of Claim Construction Hearing held on August 23, 2021 before Judge Leonard P. Stark. Court Reporter Brian Gaffigan email: gaffigan@verizon.net. Transcript may be viewed at the court public terminal or ordered/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 9/20/2021. Redacted Transcript Deadline set for 9/30/2021. Release of Transcript Restriction set for 11/29/2021. (bpg)
Aug 23, 2021 N/A Markman Hearing (0)
Docket Text: Minute Entry for proceedings held before Judge Leonard P. Stark - Markman Hearing held (by video) on 8/23/2021. (Court Reporter B. Gaffigan.) (ntl)
Aug 19, 2021 N/A Order (0)
Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that the Markman hearing on August 23, 2021 is available to the public using the following dial-in for audio access: 1-855- 747-8824 Passcode: 8975254786. Audio reproduction of the proceeding is strictly prohibited. ORDERED by Judge Leonard P. Stark on 8/19/21. (ntl)
Aug 18, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [77] MOTION for Pro Hac Vice Appearance of Attorney T.O. Kong filed by Azurity Pharmaceuticals, Inc. Signed by Judge Leonard P. Stark on 8/18/21. (ntl)
Aug 17, 2021 77 Motion for Leave to Appear Pro Hac Vice (4)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney T.O. Kong - filed by Azurity Pharmaceuticals, Inc.. (Dellinger, Megan)
Aug 16, 2021 N/A Order (0)
Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that the Markman Hearing on August 23, 2021 will begin at 5:00 p.m. and each side will be allocated up to forty-five (45) minutes for argument. ORDERED by Judge Leonard P. Stark on 8/16/21. (ntl)
Aug 12, 2021 75 Redacted Document (30)
Docket Text: REDACTED VERSION of [72] Joint Claim Construction Brief by Azurity Pharmaceuticals, Inc.. (Dellinger, Megan)
Aug 9, 2021 73 Main Document (2)
Docket Text: APPENDIX re [72] Joint Claim Construction Brief by Azurity Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit A-B)(Dellinger, Megan)
Aug 9, 2021 73 Exhibit A-B (30)
Aug 9, 2021 74 Letter (1)
Docket Text: Letter to The Honorable Leonard P. Stark from Megan E. Dellinger regarding Markman Hearing Scheduled for August 23, 2021. (Dellinger, Megan)
Aug 5, 2021 71 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Defendant Alkem Laboratories Ltd.'s Sur-Reply Claim Construction Brief for U.S. Patent Nos. 10,772,868; 10,786,482; and 10,918,621 filed by Alkem Laboratories Ltd..(Hitch, Cortlan)
Jul 29, 2021 70 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Plaintiff Azurity Pharmaceuticals, Inc.'s Reply Claim Construction Brief for U.S. Patent Nos. 10,722,868; 10,786,482; and 10,918,621 filed by Azurity Pharmaceuticals, Inc..(Dellinger, Megan)
Jul 28, 2021 69 Redacted Document (3)
Docket Text: REDACTED VERSION of [67] Stipulation regarding claim construction briefing schedule by Alkem Laboratories Ltd.. (Hitch, Cortlan)
Jul 22, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [67] [SEALED] STIPULATION Regarding Claim Construction Briefing Schedule filed by Alkem Laboratories Ltd. Signed by Judge Leonard P. Stark on 7/22/21. (ntl)
Jul 22, 2021 N/A Order (0)
Docket Text: ORAL ORDER: Having reviewed the parties' stipulation (D.I. 67), and the parties having expressed no preference on the format for the upcoming claim construction hearing, IT IS HEREBY ORDERED that the claim construction hearing on August 23 will be held remotely by videoconference. It will begin at 4:30 p.m. No later than August 20 at 4:00 p.m. the parties shall provide chambers with (i) the necessary information for it to connect to the hearing and (ii) a copy of any slides or demonstratives to which they may refer during the hearing. At the same time, the parties shall docket a public letter providing the necessary information to allow any member of the public to attend the hearing without having the ability to speak or interrupt the proceedings. ORDERED by Judge Leonard P. Stark on 7/22/21. (ntl)
Jul 16, 2021 66 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Defendant Alkem Laboratories Ltd.'s Answering Claim Construction Brief for U.S. Patent Nos. 10,772,868; 10,786,482; and 10,918,621 filed by Alkem Laboratories Ltd..(Hitch, Cortlan)
Jul 13, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [65] STIPULATION to extend time for Alkem Laboratories Ltd. to serve its answering claim construction brief and for the parties to meet and confer to submit a revised proposed schedule. Signed by Judge Leonard P. Stark on 7/13/21. (ntl)
Jul 12, 2021 65 Stipulation (2)
Docket Text: STIPULATION to extend time for Alkem Laboratories Ltd. to serve its answering claim construction brief and for the parties to meet and confer to submit a revised proposed schedule by Alkem Laboratories Ltd.. (Dorsney, Kenneth)
Jul 9, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [64] STIPULATION Regarding Production of Intervenor Bionpharma's Confidential Information by Alkem Laboratories Ltd.. Signed by Judge Leonard P. Stark on 7/9/2021. (etg)
Jul 8, 2021 64 Stipulation (2)
Docket Text: STIPULATION Regarding Production of Intervenor Bionpharma's Confidential Information by Alkem Laboratories Ltd.. (Hitch, Cortlan)
Jul 2, 2021 63 Letter (1)
Docket Text: Letter to The Honorable Leonard P. Stark from Kenneth L. Dorsney regarding status of protective order dispute - re [58] Stipulation, [59] Order,. (Dorsney, Kenneth)
Jun 30, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [62] STIPULATION and Order to Amend Schedule for Claim Construction Briefing filed by Alkem Laboratories Ltd. Signed by Judge Leonard P. Stark on 6/30/21. (ntl)
Jun 29, 2021 62 Stipulation (2)
Docket Text: STIPULATION to Amend Schedule for Claim Construction Briefing by Alkem Laboratories Ltd.. (Hitch, Cortlan)
Jun 16, 2021 60 Notice of Appearance (1)
Docket Text: NOTICE of Appearance by John C. Phillips, Jr on behalf of Bionpharma Inc. (Phillips, John)
Jun 16, 2021 61 Notice of Appearance (1)
Docket Text: NOTICE of Appearance by Megan C. Haney on behalf of Bionpharma Inc. (Haney, Megan)
Jun 11, 2021 N/A Order (0)
Docket Text: ORAL ORDER: Having reviewed the parties' various submissions in the Alkem matter (C.A. No. 19-2100), the parties' proposed stipulation (D.I. 58) is SO ORDERED. The pending Motion to Intervene (D.I. 48) is GRANTED to the extent set forth in the stipulation (D.I. 58). IT IS FURTHER ORDERED that the parties' unopposed motion to substitute Azurity Pharmaceuticals, Inc. for Silvergate (D.I. 57) is GRANTED. ORDERED by Judge Leonard P. Stark on 6/11/21. (ntl)
Jun 10, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (30 in 1:21-cv-00196-LPS, 33 in 1:20-cv-00753-LPS, 53 in 1:19-cv-02100-LPS) STIPULATION TO EXTEND TIME Opposition to Motion to Intervene to June 18, 2021 filed by Alkem Laboratories Ltd. Signed by Judge Leonard P. Stark on 6/10/21. Associated Cases: 1:19-cv-02100-LPS, 1:20-cv-00753-LPS, 1:21-cv-00196-LPS (ntl)
Jun 10, 2021 57 Motion to Substitute Party (4)
Docket Text: MOTION to Substitute Party: Azurity Pharmaceuticals, Inc. to replace Silvergate Pharmaceuticals, Inc. - filed by Silvergate Pharmaceuticals, Inc.. (Dellinger, Megan)
Jun 10, 2021 58 Stipulation (3)
Docket Text: STIPULATION Regarding Bionpharma Intervention by Alkem Laboratories Ltd.. (Hitch, Cortlan)
Jun 9, 2021 56 Notice Requesting Removal of Co-Counsel (4)
Docket Text: NOTICE requesting Clerk to remove Yan-Xin Li as co-counsel.. (Dellinger, Megan)
Jun 8, 2021 55 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Opening Claim Construction Brief for U.S. Patent Nos. 10,722,868; 10,786,482; and 10,918,621 filed by Silvergate Pharmaceuticals, Inc..(Dellinger, Megan)
Jun 4, 2021 53 Stipulation to EXTEND Time (3)
Docket Text: STIPULATION TO EXTEND TIME Opposition to Motion to Intervene to June 18, 2021 - filed by Alkem Laboratories Ltd.. (Hitch, Cortlan)
Jun 4, 2021 54 Statement (3)
Docket Text: STATEMENT re [48] MOTION to Intervene for purposes of filing a motion for protective order to protect Third Party Bionpharma's sealed confidential information-- Plaintiff's Statement of Non-Opposition -- by Silvergate Pharmaceuticals, Inc.. (Dellinger, Megan)
Jun 2, 2021 52 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Plaintiff Silvergate Pharmaceuticals, Inc.'s Objections and Response to Defendant Alkem Laboratories Ltd.'s First Set of Requests for the Production of Documents and Things (No. 1) filed by Silvergate Pharmaceuticals, Inc..(Dellinger, Megan)
May 27, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [50] STIPULATION and [Proposed] Order Regarding Joint Claim Construction Chart Deadline filed by Silvergate Pharmaceuticals, Inc. Signed by Judge Leonard P. Stark on 5/27/21. (ntl)
May 26, 2021 51 Main Document (3)
Docket Text: CLAIM Construction Chart by Silvergate Pharmaceuticals, Inc.. (Attachments: # (1) Exhibits A-C)(Dellinger, Megan)
May 26, 2021 51 Exhibits A-C (489)
May 25, 2021 50 Stipulation (1)
Docket Text: STIPULATION and [Proposed] Order Regarding Joint Claim Construction Chart Deadline by Silvergate Pharmaceuticals, Inc.. (Dellinger, Megan)
May 21, 2021 48 Main Document (2)
Docket Text: MOTION to Intervene for purposes of filing a motion for protective order to protect Third Party Bionpharma's sealed confidential information - filed by Bionpharma Inc.. (Attachments: # (1) Proposed Order, # (2) 7.1.1. Statement)(Phillips, John)
May 21, 2021 48 Proposed Order (1)
May 21, 2021 48 7.1.1. Statement (1)
May 21, 2021 49 Main Document (8)
Docket Text: MEMORANDUM in Support re [48] MOTION to Intervene for purposes of filing a motion for protective order to protect Third Party Bionpharma's sealed confidential information filed by Bionpharma Inc..Answering Brief/Response due date per Local Rules is 6/4/2021. (Attachments: # (1) Exhibit A)(Phillips, John)
May 21, 2021 49 Exhibit A (5)
May 20, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [47] STIPULATION and [Proposed] Order Regarding Certain Claim Construction Deadlines and Foregoing Technology Tutorials -- Joint Claim Construction Brief due by 7/30/2021. Signed by Judge Leonard P. Stark on 5/20/21. (ntl)
May 18, 2021 47 Stipulation (3)
Docket Text: STIPULATION and [Proposed] Order Regarding Certain Claim Construction Deadlines and Foregoing Technology Tutorials by Silvergate Pharmaceuticals, Inc.. (Dellinger, Megan)
May 13, 2021 46 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Alkem's Identification of Claim Terms and Constructions for U.S. Patent Nos. 10,772,868 B2; 10,918,621 B2; and 10,786,482 B2 filed by Alkem Laboratories Ltd..(Dorsney, Kenneth)
May 7, 2021 45 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Defendant Alkem Laboratories Ltd.'s Initial Invalidity Contentions regarding U.S. Patent Nos. 10,772,868 B2; 10,918,621 B2; and 10,786,482 B2 filed by Alkem Laboratories Ltd..(Dorsney, Kenneth)
Apr 28, 2021 44 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of First set of requests for production filed by Alkem Laboratories Ltd..(Dorsney, Kenneth)
Apr 22, 2021 42 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of (1) Plaintiff Silvergate Pharmaceuticals, Inc.'s Amended Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery; (2) Plaintiff Silvergate Pharmaceuticals, Inc.'s Amended Identification of Accused Products and Asserted Patents Pursuant to Paragraph 4.a of the Delaware Default Standard for Discovery; (3) Plaintiff Silvergate Pharmaceuticals, Inc.'s Amended Initial Disclosures Pursuant to Rule 26(a)(1); and (4) Plaintiff Silvergate Pharmaceuticals, Inc.'s Initial Infringement Claim Charts filed by Silvergate Pharmaceuticals, Inc..(Dellinger, Megan)
Apr 22, 2021 43 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of (1) Alkem's response to Plaintiff's First Set of Common Interrogatories (Nos. 1-10); and (2) Alkem's response to Plaintiff's First Set of Requests for Production (Nos. 1-64) filed by Alkem Laboratories Ltd..(Dorsney, Kenneth)
Apr 20, 2021 41 Answer to Amended Complaint (23)
Docket Text: ANSWER to Amended Complaint, re: [39] Amended Complaint by Alkem Laboratories Ltd..(Dorsney, Kenneth)
Apr 13, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [36] STIPULATION and [Proposed] Order to File First Amended Complaint filed by Silvergate Pharmaceuticals, Inc. Signed by Judge Leonard P. Stark on 4/8/21. (ntl)
Apr 13, 2021 38 SO ORDERED (5)
Docket Text: SO ORDERED, re [37] Joint MOTION to Amend the Case Schedule and Set a New Trial Date filed by Silvergate Pharmaceuticals, Inc. -- Fact Discovery completed by 10/5/2021. Joint Claim Construction Brief due by 7/23/2021. Proposed Pretrial Order due by 3/18/2022. Status Report due by 9/9/2021. A 5-day Bench Trial is set for 4/4/2022 at 08:30 AM in Courtroom 6B before Judge Leonard P. Stark. A Final Pretrial Conference is set for 3/25/2022 at 09:00 AM in Courtroom 6B before Judge Leonard P. Stark. A Markman Hearing is set for 8/23/2021 at 09:00 AM before Judge Leonard P. Stark. Signed by Judge Leonard P. Stark on 4/8/21. (ntl)
Apr 13, 2021 39 Main Document (17)
Docket Text: First AMENDED COMPLAINT against Alkem Laboratories Ltd.- filed by Silvergate Pharmaceuticals, Inc.. (Attachments: # (1) Exhibits A-G)(Dellinger, Megan)
Apr 13, 2021 39 Exhibits A-G (197)
Apr 13, 2021 40 Patent/Trademark Report to Commissioner (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,669,008 ;9,808,442 ;10,039,745 ;10,154,987 ;10,772,868 ;10,786,482 ;10,918,621 . (Dellinger, Megan)
Apr 13, 2021 39 Amended Complaint* (1)
Apr 8, 2021 36 Main Document (2)
Docket Text: STIPULATION and [Proposed] Order to File First Amended Complaint by Silvergate Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Dellinger, Megan)
Apr 8, 2021 36 Exhibit 1 (215)
Apr 8, 2021 36 Exhibit 2 (18)
Apr 8, 2021 37 Motion for Miscellaneous Relief (5)
Docket Text: Joint MOTION to Amend the Case Schedule and Set a New Trial Date - filed by Silvergate Pharmaceuticals, Inc.. (Dellinger, Megan)
Apr 6, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [34] STIPULATION TO EXTEND TIME for the parties to file an interim status report to April 7, 2021 filed by Alkem Laboratories Ltd. Signed by Judge Leonard P. Stark on 4/5/21. (ntl)
Apr 1, 2021 35 Status Report (1)
Docket Text: Interim STATUS REPORT by Alkem Laboratories Ltd.. (Dorsney, Kenneth)
Mar 31, 2021 34 Stipulation to EXTEND Time (1)
Docket Text: STIPULATION TO EXTEND TIME for the parties to file an interim status report to April 7, 2021 - filed by Alkem Laboratories Ltd.. (Dorsney, Kenneth)
Mar 25, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [33] Joint STIPULATION TO EXTEND TIME regarding certain claim construction deadlines to various dates filed by Silvergate Pharmaceuticals, Inc. Signed by Judge Leonard P. Stark on 3/24/21. (ntl)
Mar 23, 2021 33 Stipulation to EXTEND Time (2)
Docket Text: Joint STIPULATION TO EXTEND TIME regarding certain claim construction deadlines to various dates - filed by Silvergate Pharmaceuticals, Inc.. (Dellinger, Megan)
Mar 4, 2021 32 Claim Construction Chart (3)
Docket Text: CLAIM Construction Chart by Silvergate Pharmaceuticals, Inc.. (Dellinger, Megan)
Feb 25, 2021 31 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Plaintiff Silvergate Pharmaceuticals, Inc.'s Disclosure of Proposed Claim Terms and Constructions for U.S. Patent Nos. 9,669,008, 9,808,442, 10,039,745, 10,154,987, 10,772,868, 10,786,482, and 10,918,621 filed by Silvergate Pharmaceuticals, Inc..(Dellinger, Megan)
Feb 19, 2021 30 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of (1) Plaintiff Silvergate Pharmaceuticals, Inc.'s First Set of Common Interrogatories (Nos. 1-10); and (2) Plaintiff Silvergate Pharmaceuticals, Inc.'s First Set of Requests for Production (Nos. 1-64) filed by Silvergate Pharmaceuticals, Inc..(Dellinger, Megan)
Feb 18, 2021 29 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Alkem's Initial Invalidity Contentions filed by Alkem Laboratories Ltd..(Dorsney, Kenneth)
Jan 13, 2021 28 SO ORDERED (2)
Docket Text: SO ORDERED, re [27] Joint MOTION Requesting New Markman Hearing Date and Amending the Case Schedule -- Fact Discovery completed by 6/14/2021. Joint Claim Construction Brief due by 4/29/2021. Status Report due by 3/31/2021. A Markman Hearing is set for 5/20/2021 at 04:00 PM before Judge Leonard P. Stark. Signed by Judge Leonard P. Stark on 1/11/21. (ntl)
Jan 8, 2021 27 Motion for Miscellaneous Relief (2)
Docket Text: Joint MOTION Requesting New Markman Hearing Date and Amending the Case Schedule - filed by Silvergate Pharmaceuticals, Inc.. (Dellinger, Megan)
Dec 22, 2020 26 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Initial Infringement Claim Charts filed by Silvergate Pharmaceuticals, Inc..(Dellinger, Megan)
Nov 24, 2020 25 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Alkem's Core Technical Documents filed by Alkem Laboratories Ltd..(Dorsney, Kenneth)
Oct 30, 2020 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [24] STIPULATION TO EXTEND TIME for Production of Core Technical Documents and Plaintiff's Initial Infringement Contentions to November 24, 2020 and December 22, 2020 filed by Silvergate Pharmaceuticals, Inc. Signed by Judge Leonard P. Stark on 10/30/20. (ntl)
Oct 30, 2020 24 Stipulation to EXTEND Time (1)
Docket Text: STIPULATION TO EXTEND TIME for Production of Core Technical Documents and Plaintiff's Initial Infringement Contentions to November 24, 2020 and December 22, 2020 - filed by Silvergate Pharmaceuticals, Inc.. (Dellinger, Megan)
Oct 20, 2020 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [23] Stipulated Protective Order filed by Silvergate Pharmaceuticals, Inc. Signed by Judge Leonard P. Stark on 10/19/20. (ntl)
Oct 15, 2020 23 Proposed Order (26)
Docket Text: PROPOSED ORDER Stipulated Protective Order by Silvergate Pharmaceuticals, Inc.. (Dellinger, Megan)
Oct 8, 2020 22 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Plaintiff Silvergate Pharmaceuticals, Inc.'s Identification of Accused Products and Asserted Patents Pursuant to Paragraph 4.a of the Delaware Default Standard for Discovery filed by Silvergate Pharmaceuticals, Inc..(Dellinger, Megan)
Oct 1, 2020 20 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Plaintiff Silvergate Pharmaceuticals Inc.'s Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Silvergate Pharmaceuticals, Inc..(Dellinger, Megan)
Oct 1, 2020 21 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Alkem's Paragraph 3 Disclosures filed by Alkem Laboratories Ltd..(Dorsney, Kenneth)
Sep 30, 2020 18 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Initial Disclosures Pursuant to Rule 26(a)(1) filed by Silvergate Pharmaceuticals, Inc..(Dellinger, Megan)
Sep 30, 2020 19 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Alkem's Rule 26(a)(1) Initial Disclosures filed by Alkem Laboratories Ltd..(Dorsney, Kenneth)
Sep 24, 2020 N/A Case Referred to Mediation (0)
Docket Text: CASE REFERRED to Magistrate Judge Christopher J. Burke for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf (cak)
Sep 24, 2020 N/A Oral Order (0)
Docket Text: ORAL ORDER: If during the history of this case, Plaintiff(s) and Defendant(s) jointly wish to schedule a form of alternative dispute resolution ("ADR"), such as mediation, with Judge Burke, they should contact chambers by e-mail at Deborah_Benyo@ded.uscourts.gov or by phone. Additionally, if either side wishes to speak ex parte with Judge Burke regarding ADR matters, they may contact chambers via e-mail or by phone to arrange a time for a call. Ordered by Judge Christopher J. Burke on 9/24/2020. (dlb)
Sep 23, 2020 15 Scheduling Order (15)
Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Fact Discovery completed by 5/7/2021. Status Report due by 3/31/2021. Joint Claim Construction Brief due by 3/23/2021. A Markman Hearing is set for 4/5/2021 at 09:00 AM in Courtroom 6B before Judge Leonard P. Stark. Proposed Pretrial Order due by 12/30/2021. A Final Pretrial Conference is set for 1/7/2022 at 11:30 AM in Courtroom 6B before Judge Leonard P. Stark. A 5-day Bench Trial is set for 1/24/2022 at 08:30 AM in Courtroom 6B before Judge Leonard P. Stark. Signed by Judge Leonard P. Stark on 9/23/20. (ntl)
Sep 23, 2020 N/A Order Cancelling Deadline (0)
Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that the teleconference scheduled for September 25 is CANCELLED. ORDERED by Judge Leonard P. Stark on 9/23/20. (ntl)
Sep 21, 2020 14 Main Document (15)
Docket Text: PROPOSED ORDER Scheduling Order by Silvergate Pharmaceuticals, Inc.. (Attachments: # (1) Letter to Judge Stark)(Dellinger, Megan)
Sep 21, 2020 14 Letter to Judge Stark (1)
Sep 18, 2020 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Kristina M. Hanson for Silvergate Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal)
Sep 11, 2020 N/A Order Setting Teleconference (0)
Docket Text: ORAL ORDER: Having reviewed the parties' August 3, 2020 letter (D.I. 12), IT IS HEREBY ORDERED that the Court will hold a scheduling conference on September 25, 2020 at 3:00 p.m. The parties shall meet and confer and submit a proposed scheduling order no later than September 21, 2020. The parties shall use the following dial-in information: 877-336-1829 and access code 1408971. ORDERED by Judge Leonard P. Stark on 9/11/20. (ntl)
Aug 3, 2020 12 Letter (1)
Docket Text: Letter to The Honorable Leonard P. Stark from Kenneth L. Dorsney regarding request for a Rule 16(b) Scheduling Conference. (Dorsney, Kenneth)
May 8, 2020 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorneys George J. Barry, III and Timothy H. Kratz for Alkem Laboratories Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd)
May 5, 2020 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [11] MOTION for Pro Hac Vice Appearance of Attorney George J. Barry III and Attorney Timothy H. Kratz filed by Alkem Laboratories Ltd. Signed by Judge Leonard P. Stark on 5/5/20. (ntl)
May 5, 2020 11 Motion for Leave to Appear Pro Hac Vice (4)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney George J. Barry III and Attorney Timothy H. Kratz - filed by Alkem Laboratories Ltd.. (Dorsney, Kenneth)
Feb 20, 2020 9 Answer to Complaint (15)
Docket Text: ANSWER to [1] Complaint, by Alkem Laboratories Ltd..(Dorsney, Kenneth)
Feb 20, 2020 10 Disclosure Statement (1)
Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Alkem Laboratories Ltd.. (Dorsney, Kenneth)
Feb 3, 2020 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Talin Gordnia for Silvergate Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd)
Jan 29, 2020 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Wendy L. Devine for Silvergate Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal)
Jan 29, 2020 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Yan-Xin Li for Silvergate Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal)
Jan 29, 2020 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Natalie J. Morgan for Silvergate Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal)
Jan 28, 2020 8 Affidavit of Service (9)
Docket Text: AFFIDAVIT of Service for Summons, Complaint and related papers served on Alkem Laboratories Ltd. on January 28, 2020, filed by Silvergate Pharmaceuticals, Inc.. (Dellinger, Megan)
Jan 10, 2020 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (38 in 1:19-cv-00678-LPS, 48 in 1:18-cv-01962-LPS, 36 in 1:19-cv-01067-LPS, 7 in 1:19-cv-02100-LPS) MOTION for Pro Hac Vice Appearance of Attorney Talin Gordnia filed by Silvergate Pharmaceuticals, Inc. Signed by Judge Leonard P. Stark on 1/10/2020. Associated Cases: 1:18-cv-01962-LPS, 1:19-cv-00678-LPS, 1:19-cv-01067-LPS, 1:19-cv-02100-LPS (ntl)
Jan 9, 2020 7 Motion for Leave to Appear Pro Hac Vice (6)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Talin Gordnia - filed by Silvergate Pharmaceuticals, Inc.. (Dellinger, Megan)
Nov 15, 2019 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (11 in 1:19-cv-01067-LPS, 6 in 1:19-cv-02100-LPS) MOTION for Pro Hac Vice Appearance of Attorney Wendy L. Devine, Kristina M. Hanson, Yan-Xin Li, and Natalie J. Morgan filed by Silvergate Pharmaceuticals, Inc. Signed by Judge Leonard P. Stark on 11/15/19. Associated Cases: 1:19-cv-01067-LPS, 1:19-cv-02100-LPS (ntl) Modified on 1/29/2020 (ntl).
Nov 14, 2019 6 Motion for Leave to Appear Pro Hac Vice (8)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Wendy L. Devine, Kristina M. Hanson, Yan-Xin Li, and Natalie J. Morgan - filed by Silvergate Pharmaceuticals, Inc. (Dellinger, Megan) Modified on 1/29/2020 (ntl).
Nov 13, 2019 N/A Case Assigned/Reassigned (0)
Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb)
Nov 6, 2019 N/A Summons Issued (0)
Docket Text: Summons Issued with Magistrate Consent Notice attached as to Alkem Laboratories Ltd. on 11/6/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (sam)
Nov 5, 2019 1 Main Document (11)
Docket Text: COMPLAINT for patent infringement filed against Alkem Laboratories Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2771746.) - filed by Silvergate Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit A-D, # (2) Civil Cover Sheet)(sam)
Nov 5, 2019 1 Exhibit A-D (109)
Nov 5, 2019 1 Civil Cover Sheet (1)
Nov 5, 2019 2 Magistrate Consent Forms (3)
Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sam)
Nov 5, 2019 3 ANDA Form (1)
Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: September 25, 2019. Date of Expiration of Patent: March 25, 2036.Thirty Month Stay Deadline: 03/25/2022. (sam)
Nov 5, 2019 4 Patent/Trademark Report to Commissioner (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,669,008 B1 ;9,808,442 B2 ;10,039,745 B2 ;10,154,987 B2. (sam)
Nov 5, 2019 5 Disclosure Statement (1)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent CutisPharma, Inc. for Silvergate Pharmaceuticals, Inc. filed by Silvergate Pharmaceuticals, Inc. (sam)
Nov 5, 2019 1 Complaint* (1)
Menu